Table 1:
Unadjusted person-year characteristics of commercial health plan enrollees diagnosed with OUD (2008–2016), and stratified by OUD treatment received (N= 87,877 persons and 122,708 person-years).
| Total | ||
|---|---|---|
| N | % | |
| Age group | ||
| 17–25 | 26,988 | 22.0 |
| 26–35 | 27,355 | 22.3 |
| 36–45 | 24,589 | 20.0 |
| 46–55 | 25,794 | 21.0 |
| 56–64 | 17,982 | 14.7 |
| Employee | 59,959 | 48.9 |
| Female | 51,922 | 42.3 |
| US Region | ||
| Northeast | 39,037 | 31.8 |
| Midwest | 12,747 | 10.4 |
| West | 25,083 | 20.4 |
| South | 45,841 | 37.4 |
| Urban | 113,373 | 92.4 |
| Comorbid mental health condition | 77,721 | 63.3 |
| Comorbid substance use disorder | 58,877 | 48.0 |
| OUD overdose claim | 7,450 | 6.1 |
| OUD moderate/severe | 113,647 | 92.6 |
| Inpatient | 18,479 | 15.1 |
| Year | ||
| 2008 | 9,161 | 7.5 |
| 2009 | 11,035 | 9.0 |
| 2010 | 10,756 | 8.8 |
| 2011 | 11,558 | 9.4 |
| 2012 | 13,042 | 10.6 |
| 2013 | 14,101 | 11.5 |
| 2014 | 15,600 | 12.7 |
| 2015 | 17,256 | 14.1 |
| 2016 | 20,199 | 16.5 |
| OUD treatment received | ||
| MOUD & psychosocial visits | 9,959 | 8.1 |
| MOUD but no psychosocial visits | 34,543 | 28.2 |
| Psychosocial visits but no MOUD | 8,853 | 7.2 |
| Neither MOUD nor psychosocial visits | 69,353 | 56.5 |